2nd DECENTRALIZED & HYBRID CLINICAL TRIALS WORLD CONGRESS 2026 EUROPE
Redefining Clinical Research Through Decentralization, Technology, and Collaboration
Wednesday 25th - Thursday 26th February 2026
Facilitate Live is very pleased to welcome you to our upcoming 2nd Decentralized & Hybrid Clinical Trials World Congress 2026 Europe.
DCTs continue to transform the landscape of clinical research by enabling studies to be conducted beyond traditional trial sites. This flexible approach allows participants to complete study activities from home, local healthcare facilities, or nearby laboratories reducing or eliminating the need to travel to a central research location. Supported by virtual collaboration among investigators and local medical teams, DCTs leverage digital health technologies such as mobile applications, wearable devices, telemedicine, video consultations, and home health visits. Together, these innovations expand access to diverse participant populations and accelerate the collection of high-quality real-world data in a more cost-effective and patient centric manner.
As decentralized protocols gain global traction, they are redefining patient engagement by offering greater flexibility and choice —particularly valuable for individuals with rare conditions, mobility limitations, or those living in remote areas. The advantages of DCTs are far reaching, including reduced barriers to participation, improved diversity and inclusion in clinical trials, enhanced recruitment and retention, opportunities to study low-prevalence diseases, shorter development timelines, faster access to innovative therapies, and improved data accuracy—all contributing to more efficient and equitable healthcare delivery.
However, DCTs also bring new considerations. Trial design must address the complexities of data collection, management, and interoperability across multiple digital platforms. Variability in technology use can affect data quality, and participants may face challenges using connected devices correctly. Therefore, researchers must ensure that consent, data entry, and withdrawal processes are intuitive and patient friendly. Strong data privacy and cybersecurity measures are essential to safeguard sensitive information. Ensuring participant safety, managing potential technology failures, and maintaining regulatory compliance across jurisdictions remain critical priorities. Additionally, hybrid approaches should continue to accommodate participants who prefer in person visits or require additional support using digital tools.
The 2nd Decentralized and Hybrid Trials World Congress 2026 – Europe will convene leading experts, regulators, technology innovators, and patient representatives to discuss strategies, share best practices, and showcase new technologies driving the next phase of decentralized research. Attendees can look forward to an engaging, collaborative, and forward thinking exchange of ideas designed to advance the global adoption and impact of DCTs.
We look forward to welcoming you to the Decentralized & Hybrid Clinical Trials World Congress 2026 Europe.
Sincerely yours,
Jocelyn Raguindin
Conference Director
Facilitate Live
Gain The Latest Insights On:
- Overcoming Implementation Barriers: Identify and mitigate common hurdles in adopting decentralized research.
- Enhancing Participant Experience: Improve convenience, engagement, and support for patients in DCTs.
- Optimizing Communication and Productivity: Address challenges in communication and workflow efficiency within decentralized trials.
- Navigating Regulatory Landscape: Understand current and emerging regulatory guidelines for DCT compliance and ethics.
- Ensuring Patient Safety and Data Integrity: Assess the impact of decentralized elements on safety and implement measures to reduce errors.
- Achieving Patient Centricity: Balance research efficacy and participant well being in DCTs.
- Driving Growth and Success: Foster the continued success and expansion of decentralized clinical trials.
- Broadening Diversity, Equity, and Inclusion (DEI): Leverage technology to enhance participant diversity, equity, and inclusion.
- Key Planning and Execution Milestones: Understand essential milestones for successful DCT planning and execution.
- Industry Collaboration and Leadership Insights: Network with leaders to gain operational insights and ethical guidance on Hybrid & Full DCTs.
Sponsorship & Exhibit Opportunities
Our event partners and team of experts are recognized for creating and providing unique, innovative events. We open doors and create access to business opportunities for our clients. Our events are forum for discussion, learning, showcasing new technologies, innovations, new products and trends, solutions and concepts.
The impact you make and how you get your message across at our Facilitate Live Events is up to you – we offer packages or tailor made solutions to meet your exact requirements and budget.
By sponsoring a Facilitate Live Event you will be exposed to the following:
- Access to key decision makers
- Direct access to our delegates and attendees
- Increase worldwide awareness of your organisations latest products and services
- Drive and create new business opportunities
- Generate new contacts and renewed interest for your product of expertise
- Be recognised as a key player and a key supporter of your industry sector
- Demonstrate your organization’s commitment
- Demonstrate your excellence as a technical supplier
- Show brand awareness and brand building
- Brand and product endorsements
- Extensive pre-show and post-show coverage
Solution Showcase
Showcase your latest cutting-edge solutions, new products, technology, innovations and trend. Meet face to face with high level decision makers who are in a receptive mindset and actively seeking solutions and services.
As an exhibitor you will gain access to this exclusive captive audience and have the opportunity to:
- Speak to the attendees and demonstrate your product / services at the solution showcase network to captive and receptive key decision makers
- Gain exposure to one of our Facilitate Live
- Host a networking drinks reception or lunch for attendees
- Meet one-on-one with attendees
- Generate a high number of leads with senior decision makers
- Meet your peers and exhibit alongside your competitors
- Present case studies and in-depth information in a solution provider showcase session
- Present case studies and in-depth information in a solution provider showcase session
- Educate the market with your product and technology solutions
Sponsorship & Exhibit Inquiries
Email: Sponsor@facilitatelive.com Tel No: +44 (0)207 193 3485
Who Should Attend:
This Congress will provide information to pharmaceutical and biotech companies, researchers, physicians, institutional review boards (IRBs), patient organizations and advocates, and regulatory agencies about the implementation of Real-World Evidence.
Network with members of the boards, VP’s, Directors, Heads/Chiefs, and Senior Managers of leading Pharmaceuticals and Biotech Companies, Government, CRO’s and Solution Providers Involved in:
- Decentralized Clinical Trials Operations
- Hybrid Trials
- Clinical Data Management
- Clinical Development & Operations
- Clinical Trial Tools & Technologies
- Clinical Strategy
- Patient Engagement
- Data Management
- Digital Health Process & Solution
- Clinical Research
- Statistical Scientist
- Regulatory Affairs
- Clinical Studies
- Clinical Operations
- Clinical Trial Site
- Trial Designs
- Patient Advocacy
- Consultant
- Clinical Research
- Global Development Solutions
- Electronic Clinical Outcome Assessment (eCOA)
- Contract Research Organizations
- Medical Affairs, Global Patient Advocacy & Alliances
- Government Policy and Advocacy
- Digital Patient Experience Lead
- Clinical Insights and Experience
- Head of Strategy, Access Services
- Product Lifecycle
- Patient and Disease Registries
- Scientific Affairs
- Electronic & Medical Records
- Lab & Biomarkers
- Medical and Pharmacy data
- Clinical Supply Chain Management
- Digital Strategy and Engagement
- Patient Recruitment and Retention
- Academia
- And much more…
Co-located with Patient Centricity & Collaboration World Congress 2026 Europe.
Joint Networking & Exhibit Area.
Website: www.patientcentricityworld.com
Regulation, Collaboration, and Patient Engagement
- Key updates on the CTR and its practical implications for DCT operations
- Coordinating approvals via the Clinical Trials Information System (CTIS)
- Managing ethics submissions and multi-country compliance challenges
- Building trust and transparency through harmonized EU oversight
Moderator:
Panelist:
- How the EU4Health and European Health Data Space (EHDS) initiatives enable DCT expansion
- EMA’s digital strategy and its implications for decentralized research oversight
- The evolution of national frameworks for telemedicine and remote care integration
- Envisioning Europe’s role as a global leader in digital clinical innovation
- Implementation lessons from Spain, Germany, France, and the Nordics
- Cross-border participant management and data sharing under GDPR
- Addressing operational fragmentation between national health systems
- Opportunities for mutual recognition and data reuse in the EU
- Adapting GCP principles for hybrid and home-based trial oversight
- Maintaining clinical responsibility across decentralized trial settings
- Leveraging digital dashboards and telemonitoring tools for supervision
- Supporting site staff through EU-level digital training frameworks
- Reducing barriers to participation for rural and aging populations
- Strategies for multi-language patient interfaces and digital inclusion
- Leveraging telehealth to improve representation in rare disease studies
- Building national digital literacy programs for broader engagement
- Advances in validated wearables, eConsent, and ePRO platforms
- Interoperability with hospital EHR systems
- Ensuring MDR/IVDR compliance for medical device-linked technologies
- Real-world deployment case studies from multi country trials
- Integrating GDPR, ethics, and consent requirements from inception
- Incorporating remote assessments and digital biomarkers
- Aligning decentralized protocol elements with local legislation
- Collaborative approaches to co-design with patients and advocacy groups
- Importance of strong relationship with sites and site network critical to the success of clinical trials
- Strategies sponsors can develop to build strong site relationships at scale.
- Key factors that are highly valued by both Contract Research Organisations (CROs) and Sponsors.
- Future directions for improving relationships with sites and site networks
- Managing decentralized data securely across multiple jurisdictions
- Best practices for anonymization and data minimization
- Cyber resilience in sponsor, CRO, and technology partnerships
- Building public confidence through transparent privacy frameworks
- Blending virtual and in-person interactions to enhance experience
- Supporting patients through multilingual, digital, and in-clinic channels
- Ensuring safety, adherence, and satisfaction in hybrid environments
- The path toward a unified, inclusive European patient-centric model
- Implementation of centralized monitoring models in EU pilot studies
- Handling eSource verification and remote audits under GCP
- Coordinating across multi-language data environments
- Lessons learned from recent decentralized oncology and vaccine trials
- Fostering pan-European ecosystems for DCT service delivery
- Integrating SMEs and digital health star tups into large-scale trials
- Coordinating cross-border logistics, training, and support networks
- Establishing standardized performance and quality metrics
TECHNOLOGY, OPERATIONS AND FUTURE OUTLOOK
- Coordinating logistics and remote data management across borders
- Streamlining patient recruitment and local lab partnerships
- Managing supply chain complexities for home-delivered IMPs
- Remote monitoring and investigator coordination best practices
- Harmonizing operational standards under EMA oversight
- Scalable cloud-based data environments and interoperability
- AI-driven analytics and decentralized workflow automation
- Building resilient digital ecosystems for global research
- Standardizing APIs and digital identity systems for trial access
- Accessing national health data repositories under EHDS regulations
- Linking EHR and ePRO data to enhance endpoint validation
- Addressing data ownership and consent portability across borders
- Practical outcomes from Nordic and Benelux pilot programs
- Competency frameworks for investigators and monitors in DCTs
- EU-wide accreditation for digital trial operations training
- Adapting site culture to hybrid and remote collaboration
- Incentivizing ongoing digital literacy and skill development
- Expanding inclusive strategies to improve DCT participation across Europe.
- Embedding AI and digital tools into modern trial planning.
- Identifying savings from reduced site visits and remote operations.
- Balancing tech investment with patient engagement costs.
- Tracking shifts toward adaptive, risk-based DCT budgeting.
- Showcases of compliant digital platforms and wearables
- Evaluation criteria for security, usability, and interoperability
- Integration success stories from EU-funded collaborations
- Discussion with vendors and regulators on platform certification
- Streamlining submissions under the CTR multi-member review model
- Ensuring eConsent accessibility across languages and literacy levels
- Handling withdrawal and re-consent procedures under GDPR
- Aligning local ethics boards under unified EU ethical frameworks
- Using remote models to connect geographically dispersed patients
- Overcoming recruitment challenges through decentralized access
- Leveraging telemedicine and home sampling for small populations
- Case outcomes from recent EU-funded rare disease initiatives
- How can collaboration between regulators, industry, and academia accelerate DCT innovation across
Europe? - What funding and infrastructure models best support large-scale decentralized trial adoption?
- How can shared digital platforms improve data interoperability and transparency?
- What role will EU initiatives like Horizon Europe and IMI play in sustaining long-term DCT growth?
- How are decentralized trials evolving from pilot initiatives to Europe’s new research standard?
- How can decentralized models be effectively integrated with national healthcare systems?
- How can AI and real-world data enhance adaptive and data-driven study design?
- How can transparency and data ownership strengthen patient trust and engagement?
- How will decentralized trials become a core pillar of the European Health Union?
Moderator:
Panelists: